LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,501,000 | -6.3% | 75,496 | 0.0% | 2.43% | +12.2% |
| Q2 2022 | $6,939,000 | -16.2% | 75,496 | +2.6% | 2.17% | -7.9% |
| Q1 2022 | $8,279,000 | -21.9% | 73,596 | +7.3% | 2.35% | -24.3% |
| Q4 2021 | $10,595,000 | +13.0% | 68,596 | +1.9% | 3.11% | +10.1% |
| Q3 2021 | $9,376,000 | +6.2% | 67,296 | 0.0% | 2.82% | +10.7% |
| Q2 2021 | $8,829,000 | -11.2% | 67,296 | +3.2% | 2.55% | -18.4% |
| Q1 2021 | $9,937,000 | +69.6% | 65,180 | +10.6% | 3.13% | +25.1% |
| Q4 2020 | $5,860,000 | – | 58,921 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |